← All organizations

Ambrilia Biopharma, Inc.

For profit

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Feb 1, 2008

Defunct as of Jul 31, 2011

Timeline

2000s

Jun 1, 2006
Ambrilia Biopharma, Inc.— Founded

2010s

Jul 31, 2011
Ambrilia Biopharma, Inc.— Defunct

Drugs by trial phase (2 distinct, 4 trials)

Phase 3 (1 own, 0 via acquisition)

octreotide

Phase 1 (1 own, 0 via acquisition)

tigapotide

Indications

Studied for

Recent trials (7)

NCT00642421Study directorPhase 3Feb 1, 2008
NCT00642421Lead sponsorPhase 3Feb 1, 2008
NCT00635765Lead sponsorPhase 3Oct 1, 2007
NCT00635765Study directorPhase 3Oct 1, 2007
NCT00616551Study directorPhase 3Apr 1, 2007
NCT00616551Lead sponsorPhase 3Apr 1, 2007
NCT00695851CollaboratorPhase 1Mar 1, 2005

Details

Founded: Montreal, CA Jun 1, 2006
Last known activity: Feb 1, 2008